Raw Ame IVS: Financial statements 2018
CVR: 36455187
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Raw Ame IVS (CVR 36455187) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -10,133 the year before. Equity in the 2018 report amounted to DKK -9,933.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -9,933
- Total Assets
- DKK 30
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 0 | 0 | -10 t. | - |
| 2017 | - | -170 | -10 t. | -10 t. | - |
| 2016 | 0 | 0 | 0 | 200 | - |
| 2015 | 0 | 0 | 0 | 1 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Raw Ame IVS has published its annual report for 2017. Gross profit came to DKK -170, and the net result was DKK -10,133.
As of March 1, 2018, Martin Aarhus Gregersen is registered as director of Raw Ame IVS.
As of March 1, 2018, Rasmus Hyldal Lynegaard Henningsen is registered as adm. dir. of Raw Ame IVS.
As of March 1, 2018, Frederik Halbak has stepped down as director of Raw Ame IVS.
As of February 20, 2018, Joseph Juel Saoor has stepped down as director of Raw Ame IVS.
About Raw Ame IVS
Raw Ame IVS was a Danish company of the type Iværksætterselskab based in København V, founded in 2014. The company has been dissolved on 8 April 2021. The company was registered under the industry Webportaler. The company was previously named GOPARE IVS. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -10,133 the year before. Equity in the 2018 report amounted to DKK -9,933.